PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826F04QB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $37,878
Award facts
- Contract value 100% obligated
- $37,878.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded November 4, 2025, represents a $37,878.38 firm fixed price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery to support federal medical procurement needs. The award is issued under the company's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The DLA Medical Supply Chain, the funding federal agency, utilizes AmerisourceBergen's pharmaceutical distribution capabilities to supply critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally. The contract carries no set-aside designation, indicating it was competitively awarded, and involves delivery to the company's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025.
AmerisourceBergen Drug Corp's role as a major pharmaceutical distributor positions it as a critical vendor for federal medical procurement, serving defense and civilian healthcare systems including the Defense Health Agency and U.S. Coast Guard. As a child contract under the larger DLA prime IDV, this delivery order exemplifies the company's substantial federal contracting portfolio, which historically demonstrates versatility in fulfilling medical supply needs ranging from small transactions to substantial orders. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative envisions multiple regional awards among different contractors, underscoring AmerisourceBergen's competitive standing within the federal pharmaceutical supply ecosystem.
Quick answers
Who was awarded contract SPE2D826F04QB?
SPE2D826F04QB was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on November 4, 2025.
How much is contract SPE2D826F04QB worth?
The government has obligated $37,878 on SPE2D826F04QB.
Is contract SPE2D826F04QB an order under another contract?
Yes. SPE2D826F04QB is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F04QB competed?
The extent of competition for SPE2D826F04QB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award